Medpace Holdings Inc diskutieren
Medpace Holdings Inc
WKN: A2APTV / Symbol: MEDP / Name: Medpace Holdings / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
345,10 €
-0,63 %
Medpace Holdings, Inc. (NASDAQ: MEDP) had its price target raised by analysts at Guggenheim from $252.00 to $273.00. They now have a "buy" rating on the stock.
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $289.00 price target on the stock, up previously from $270.00.
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) had its price target raised by analysts at Robert W. Baird from $302.00 to $312.00. They now have an "outperform" rating on the stock.
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) had its price target raised by analysts at Robert W. Baird from $312.00 to $408.00. They now have an "outperform" rating on the stock.
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $452.00 price target on the stock, up previously from $282.00.
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $450.00 price target on the stock, up previously from $340.00.
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) had its price target raised by analysts at Robert W. Baird from $446.00 to $454.00. They now have an "outperform" rating on the stock.
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) had its price target raised by analysts at Guggenheim from $453.00 to $464.00. They now have a "buy" rating on the stock.
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) is now covered by analysts at Mizuho. They set a "buy" rating and a $435.00 price target on the stock.
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) is now covered by analysts at TD Cowen. They set a "buy" rating and a $452.00 price target on the stock.
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) had its price target raised by analysts at Robert W. Baird from $456.00 to $469.00. They now have an "outperform" rating on the stock.
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) had its price target lowered by analysts at Guggenheim from $464.00 to $432.00. They now have a "buy" rating on the stock.
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) had its price target lowered by analysts at TD Cowen from $452.00 to $434.00. They now have a "buy" rating on the stock.
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) had its price target lowered by analysts at Robert W. Baird from $469.00 to $430.00. They now have an "outperform" rating on the stock.
Ratings data for MEDP provided by MarketBeat
Neueste Beiträge
Deutsche_Bank_Aktien in Quaker Chemical Corp. diskutieren